Clinical Trials

Showing 1166 Clinical Trials

Sort by:

Comparison of Treatment by IN Ketamine to IV Morphine in Acute Pain

Start Date: December 2022 Updated: June 2019

Tel-Aviv, Israel

Ketamine

Phase 3

Unknown status
Ketamine for Relapse Prevention in Recurrent Depressive Disorder

Start Date: December 2022 Updated: January 2020

Dublin, Ireland

Ketamine

Phase 1

Terminated
Sodium Oxybate in Patients With Episodic and Chronic Cluster Headache

Start Date: December 2022 Updated: December 2015

GHB

Phase 3

Unknown status
Effects of Low Dose Ketamine Given at Induction of Anesthesia on Postoperative Mood in Patients With Depressive Symptoms

Start Date: December 2022 Updated: February 2018

San Antonio, Texas, USA

Ketamine

Not Applicable

Terminated
Evaluating Ketamine and Psychological Sequelae

Start Date: December 2022 Updated: August 2019

Bethesda, Maryland, USA

Ketamine

Completed
Ketamine Infusion for Pediatric Patients With Obstructive Sleep Apnea Syndrome (OSAS) After Tonsillectomy

Start Date: December 2022 Updated: October 2018

Winnipeg, Manitoba, Canada

Ketamine

Phase 4

Completed
Neuronal Correlates of Altered States of Consciousness

Start Date: December 2022 Updated: September 2015

Basel, Basel-Stadt, Switzerland

LSD

Early Phase 1

Completed
Modulation of CSF Amyloid-beta Concentrations Via Behavioral Sleep Deprivation and Pharmacological Sleep Induction

Start Date: December 2022 Updated: April 2018

Saint Louis, Missouri, USA

GHB

Not Applicable

Completed
Dose Finding Study of Single Dose GHB11L1 in Healthy Adults

Start Date: December 2022 Updated: January 2011

Vienna, Austria

GHB

Phase 2

Completed
Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor

Start Date: December 2022 Updated: January 2012

Bingham Farms, Michigan, USA

GHB

Phase 2

Completed

Clinical Trials

What Data is Included?